Can the Use of Bone Marrow Parameters Improve the Efficacy of Risk Prediction Scores in Chronic Myeloid Leukemia in Imatinib Era?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Can the Use of Bone Marrow Parameters Improve the Efficacy of Risk Prediction Scores in Chronic Myeloid Leukemia in Imatinib Era?

Published:2017-06 Issue:6 Volume:17 Page:375-381
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Kanakasetty Govind Babu,Thanky Aditi Harsh,Kuntegowdanahalli Lakshmaiah,Dasappa Lokanatha,Jacob Linu,Mallekavu Suresh Babu,Lakkavalli Rajeev,Kadabur Lokesh,Antapura Rudresha

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference40 articles.

1. Prognostic discrimination in “good-risk” chronic granulocytic leukemia;Sokal;Blood,1984

2. A new prognostic score for survival of patients with chronic myeloid leukemia treated with interferon alfa. Writing Committee for the Collaborative CML Prognostic Factors Project Group;Hasford;J Natl Cancer Inst,1998

3. Predicting complete cytogenetic response and subsequent progression-free survival in 2060 patients with CML on imatinib treatment: the EUTOS score;Hasford;Blood,2011

4. Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia;Kantarjian;N Engl J Med,2002

5. Monitoring treatment of chronic myeloid leukemia;Baccarani;Haematologica,2008

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analyzing contribution of pioneeringteachers to improv their competence in Rote Ndao district in East Nusa Tenggara;JURNAL PENDIDIKAN DASAR NUSANTARA;2024-03-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP